Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21510,125,1.42 [1.08-1.86],0.0123193637451027
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17047,431,1.33 [1.13-1.57],0.0006126614105753
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21715,40,1.81 [1.25-2.64],0.0019126645714279
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23250,95,1.38 [1.00-1.90],0.0478171851287451
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",20584,25,2.02 [1.33-3.06],0.0009986882535151
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21930,703,1.22 [1.06-1.40],0.0045020757130816
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23781,77,1.54 [1.12-2.12],0.0077146401080374
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23752,42,1.61 [1.07-2.43],0.0237821655409489
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma, any site",23754,42,1.61 [1.07-2.43],0.0237876555300963
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22988,166,1.39 [1.09-1.79],0.0084673682375024
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22877,299,1.31 [1.08-1.59],0.0065688153145003
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22877,299,1.31 [1.08-1.59],0.0065688153145003
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20321,40,1.99 [1.43-2.78],4.833995677651324e-05
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20341,60,1.56 [1.09-2.23],0.0144878048852856
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20261,268,0.71 [0.53-0.94],0.0176252137350497
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19763,157,1.47 [1.16-1.84],0.0011463953310057
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23651,128,1.54 [1.21-1.96],0.0003952422116003
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23430,266,0.70 [0.53-0.93],0.0134436278813067
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23305,141,0.57 [0.38-0.85],0.0054384523687559
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23564,38,1.60 [1.03-2.48],0.0350486052005352
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Varicose veins,23067,378,1.28 [1.07-1.52],0.0058333967269551
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21802,766,1.21 [1.07-1.38],0.0032488505420803
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22314,694,1.22 [1.07-1.39],0.0039923005214713
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Asthma,18191,694,1.21 [1.05-1.38],0.007273934035121
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18063,694,1.20 [1.05-1.38],0.0077656364019642
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18176,679,1.22 [1.06-1.40],0.005446699743413
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23669,54,1.54 [1.05-2.26],0.026102425396288
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pleural effusion,22659,65,1.44 [1.00-2.08],0.0482476218397155
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16929,4442,1.09 [1.01-1.16],0.0195385042092424
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,19084,89,1.39 [1.02-1.91],0.0382397625073187
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23743,63,1.48 [1.04-2.12],0.0311271894773139
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ventral hernia,20550,77,1.45 [1.03-2.04],0.0350811205191579
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21627,1290,1.13 [1.01-1.26],0.0259271922973992
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23154,359,1.34 [1.13-1.59],0.000958969879779
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22893,98,1.66 [1.27-2.18],0.0002071445446524
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22528,86,1.53 [1.13-2.06],0.0054221069156783
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18288,109,1.61 [1.24-2.08],0.000307854744685
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18487,308,1.30 [1.07-1.58],0.0076585989598072
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23541,104,1.60 [1.23-2.07],0.0003986758659276
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23553,92,1.59 [1.20-2.10],0.0010591531202028
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22590,57,1.48 [1.02-2.14],0.0378129005930863
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22634,101,1.41 [1.05-1.91],0.0233365067660344
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20192,3735,1.17 [1.09-1.25],7.078798335378928e-06
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22557,157,1.43 [1.12-1.83],0.0044881977292618
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22699,29,2.42 [1.76-3.31],4.423520988016592e-08
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22707,37,1.93 [1.34-2.76],0.0003709389717753
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22527,754,1.14 [1.00-1.31],0.0486653037322299
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22304,531,1.21 [1.04-1.41],0.0147967439378929
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9349,31,1.76 [1.12-2.77],0.0142048638503848
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13035,218,1.28 [1.02-1.60],0.0354154060026178
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,12956,151,1.36 [1.04-1.77],0.02466279776705
